MS CENTER OF GREATER WASHINGTON PC
MS Center of Greater Washington PC is a Vienna, Virginia neurology practice specializing exclusively in Multiple Sclerosis, founded in 2007 by Dr. Heidi Crayton. Three board-certified MS neurologists deliver chronic disease management, on-site biologic infusion therapy, and sponsored clinical trial research to Mid-Atlantic MS patients.
- Company typePrivate
- Founded2007
- HeadquartersVienna, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What MS CENTER OF GREATER WASHINGTON PC does
MS Center of Greater Washington PC is a private neurology practice (professional corporation) headquartered in Vienna, Virginia, that operates exclusively as a Multiple Sclerosis specialty center. Founded in 2007 by Dr. Heidi Crayton, the practice is described as the only full-time, non-academic MS center in the Mid-Atlantic region, with a clinical model organized around lifelong disease management rather than episodic general neurology care.
The practice is staffed by three board-certified MS neurologists — Dr. Heidi Crayton (founder and medical director), Dr. Nancy Hu, and Dr. Zachariah Hasan — supported by ten staff members. Clinical operations combine office-based neurology consultations, MRI-driven disease surveillance, and a high-volume on-site infusion suite that administers disease-modifying biologic therapies (e.g., Ocrevus, Tysabri) to 300+ infusion patients per month. The practice also serves as an active Principal Investigator site for sponsored MS clinical trials, integrating research revenue and early drug access into the standard care pathway.
Revenue is generated through fee-for-service neurology visits, infusion-administration billing (drug acquisition and/or facility fees under buy-and-bill or specialty-pharmacy models), and per-patient clinical trial budgets from biopharma sponsors. The customer base is the regional MS patient population across the Washington DC–Virginia–Maryland corridor, acquired primarily via word-of-mouth, regional neurology referrals, and the practice's own social media presence. The practice competes against academic MS programs at regional medical centers and large general neurology groups, with differentiation anchored in subspecialty depth, PI activity, and on-site infusion capability.
MS CENTER OF GREATER WASHINGTON PC firmographics
Firmographics- Name
- MS CENTER OF GREATER WASHINGTON PC
- Legal name
- MS Center of Greater Washington, P.C.
- Website
- https://drcrayton.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- MS Center of Greater Washington PC is a Vienna, Virginia neurology practice specializing exclusively in Multiple Sclerosis, founded in 2007 by Dr. Heidi Crayton. Three board-certified MS neurologists deliver chronic disease management, on-site biologic infusion therapy, and sponsored clinical trial research to Mid-Atlantic MS patients.
- Ownership category
- akta.pro rank
MS CENTER OF GREATER WASHINGTON PC industry classification
Industry- Product category
- Neurology / Multiple Sclerosis Care
- NAICS
- Offices of Physicians (except Mental Health Specialists) (621111)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)
- akta.pro secondary industry
- Neurorehabilitation Centers (HLAFAFAH)
Keywords
Where MS CENTER OF GREATER WASHINGTON PC is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
MS CENTER OF GREATER WASHINGTON PC business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Services Revenue: Revenue from patient consultations, MS diagnosis, treatment planning, and ongoing neurological care services provided by board-certified neurologists.
- Infusion Services: On-site infusion suite providing medication administration services. Serves 300+ patients per month with medications including Ocrevus, Tysabri, Briumvi, Lemtrada, and other MS therapies. Coordinates with manufacturer patient assistance programs for eligible patients.
- Clinical Trial Research: The practice conducts clinical trials as a principal investigator site, providing patients access to experimental treatments while generating research revenue.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
MS CENTER OF GREATER WASHINGTON PC product offering
Product offeringCore offering
MS Center of Greater Washington PC is a private neurology practice that diagnoses and treats Multiple Sclerosis for adult patients in the Greater Washington, D.C. area. Its core services include MS consultations and ongoing disease management, on-site infusion therapy for MS disease-modifying drugs (serving 300+ patients per month), participation in MS clinical trials, medication financial assistance, and patient education through the healow patient portal.
Product overview
MS Center of Greater Washington PC is a specialized neurology practice offering a unified suite of MS care services. The core offerings include MS Diagnosis & Treatment with personalized care plans, Clinical Trials for research access, and On-Site Infusion Services for medication administration (300+ patients monthly). Supporting services include a Patient Portal (healow) for online health management, Medication Financial Assistance programs connecting patients to manufacturer copay support, and MS Resources & Education. The practice operates as the only full-time non-academic MS center in the Mid-Atlantic, staffed by three board-certified neurologists with over 20 years of experience.
Differentiator
Problem solved
Functional benefit
Products and services
- MS Diagnosis and Treatment Comprehensive medical evaluation and ongoing disease management for adults with Multiple Sclerosis, including consultative neurology visits, diagnostic workup, and treatment planning. Patients are typically referred by primary care physicians or general neurologists.
- On-Site Infusion Therapy Infusion of MS disease-modifying therapies administered at the practice's Vienna, Virginia office, serving 300+ MS patients per month and eliminating the need for hospital-based infusion visits.
- Clinical Trial Participation Enrollment of eligible MS patients into Multiple Sclerosis clinical trials coordinated through the practice, giving patients access to investigational therapies not widely available.
- Medication Financial Assistance Coordination of patient financial assistance programs to help MS patients afford high-cost disease-modifying therapies.
- Patient Portal (healow) healow-based patient portal used for communication with the care team, access to medical records, and patient engagement between office visits.
- MS Resources and Education Educational materials and resources provided to MS patients to support understanding of disease, treatment options, and self-management.
Quantifiable outcome
- Serves 300+ patients per month through on-site infusion suite
Companies that use MS CENTER OF GREATER WASHINGTON PC
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
MS CENTER OF GREATER WASHINGTON PC technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MS CENTER OF GREATER WASHINGTON PC partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
MS CENTER OF GREATER WASHINGTON PC competitors and assessment
Company assessmentOthers
- eClinicalWorks: Provider of the healow patient portal platform used by MSCGW. Functions as a technology and patient-engagement infrastructure vendor rather than a clinical peer, but is materially relevant to the practice's day-to-day operations.
- Multiple Sclerosis Association of America (MSAA): A nonprofit patient advocacy and resource organization serving the MS community. Not a direct care provider but an ecosystem partner that influences patient referrals, education, and financial assistance pathways that MSCGW navigates for its patients.
Broad incumbents
- Biogen: Manufacturer of Tysabri, one of the key MS biologics administered in MSCGW's infusion suite. While not a direct care provider, Biogen is a critical partner in the MS treatment ecosystem and a benchmark for the pharmaceutical side of the value chain.
- Novartis Neurology (incl. Multiple Sclerosis franchise): A major pharmaceutical company that manufactures MS therapies (e.g., Kesimpta, Gilenya) directly relevant to the infusion and prescription services that MSCGW provides. As a manufacturer partner, it is a counterparty in the MS drug ecosystem the practice operates in.
- Johns Hopkins MS Center: An academic medical center MS program providing specialized MS care and clinical trials. Competes with MSCGW for complex MS patients in the broader Mid-Atlantic region and represents the academic alternative to MSCGW's non-academic model.
- Georgetown University Hospital Neurology: Academic neurology department where all three MSCGW neurologists trained. Provides a competing MS specialty practice and clinical trial site within the Washington, DC metro area, and is a natural source of referrals and talent.
- Mellen Center for Multiple Sclerosis (Cleveland Clinic): A leading academic MS center offering comprehensive MS diagnosis, treatment, infusion, and clinical trials. Operates within a large health system and represents the integrated academic specialty model against which MSCGW competes for complex referrals.
Regional players
- Shepherd Center (MS Program): A specialty rehabilitation and MS care provider in Atlanta, comparable to MSCGW's integrated care model but serving the Southeast U.S. rather than the Mid-Atlantic.
Direct peers
- MS Center of Atlanta: A specialized non-academic MS center in the Southeast, comparable to MSCGW in offering dedicated MS diagnosis, treatment, infusion, and clinical trial services within a single practice. Operates a similar specialist-only model in a different geography.
- Rocky Mountain MS Clinic: A specialty MS clinic that provides comprehensive MS care, infusions, and clinical trials. Models the same multi-neurologist, full-time MS-focused practice concept as MSCGW, though based in the Mountain West region.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
MS CENTER OF GREATER WASHINGTON PC social profiles
Digital presenceMS CENTER OF GREATER WASHINGTON PC financial estimates
Financial estimateRevenue estimate
Valuation estimate
MS CENTER OF GREATER WASHINGTON PC leadership team
Management profileNumber of profiles
Profiles1 record
MS CENTER OF GREATER WASHINGTON PC funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MS CENTER OF GREATER WASHINGTON PC M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MS CENTER OF GREATER WASHINGTON PC
What does MS CENTER OF GREATER WASHINGTON PC do?
MS Center of Greater Washington PC is a private neurology practice that diagnoses and treats Multiple Sclerosis for adult patients in the Greater Washington, D.C. area. Its core services include MS consultations and ongoing disease management, on-site infusion therapy for MS disease-modifying drugs (serving 300+ patients per month), participation in MS clinical trials, medication financial assistance, and patient education through the healow patient portal.
Is MS CENTER OF GREATER WASHINGTON PC a public or private company?
MS CENTER OF GREATER WASHINGTON PC is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MS CENTER OF GREATER WASHINGTON PC founded?
MS CENTER OF GREATER WASHINGTON PC was founded in 2007. It employs 1 to 10 people.
Where is MS CENTER OF GREATER WASHINGTON PC based?
MS CENTER OF GREATER WASHINGTON PC is headquartered in Vienna, United States, in the North America region.
How does MS CENTER OF GREATER WASHINGTON PC make money?
Three revenue lines are on record. Clinical Services Revenue is the primary driver. The others are infusion Services and clinical Trial Research.
Who are MS CENTER OF GREATER WASHINGTON PC's main competitors?
Others on record are eClinicalWorks and Multiple Sclerosis Association of America (MSAA). Broad incumbents are Biogen, Novartis Neurology (incl. Multiple Sclerosis franchise), Johns Hopkins MS Center, Georgetown University Hospital Neurology and Mellen Center for Multiple Sclerosis (Cleveland Clinic). Shepherd Center (MS Program) is listed as a regional player. Direct peers are MS Center of Atlanta and Rocky Mountain MS Clinic.
Does MS CENTER OF GREATER WASHINGTON PC have an API?
No public API is recorded for MS CENTER OF GREATER WASHINGTON PC.
What industry is MS CENTER OF GREATER WASHINGTON PC in?
MS CENTER OF GREATER WASHINGTON PC's product category is Neurology / Multiple Sclerosis Care. Its primary akta.pro industry code is HLAFAKAK, Neurodiagnostic Centers (EEG/EMG/NCS), with a secondary code of HLAFAFAH, Neurorehabilitation Centers. Its NAICS code is 621111 and its SIC code is 8011.